These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 38291582

  • 1. Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2.
    Yang L, Chen JJ, Sheng-Xian Teo B, Zhang J, Jiang M.
    Am J Chin Med; 2024; 52(1):217-230. PubMed ID: 38291582
    [Abstract] [Full Text] [Related]

  • 2. Anticancer property of ginsenoside Rh2 from ginseng.
    Li X, Chu S, Lin M, Gao Y, Liu Y, Yang S, Zhou X, Zhang Y, Hu Y, Wang H, Chen N.
    Eur J Med Chem; 2020 Oct 01; 203():112627. PubMed ID: 32702586
    [Abstract] [Full Text] [Related]

  • 3. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future.
    Guan W, Qi W.
    Phytomedicine; 2023 Sep 01; 118():154938. PubMed ID: 37406390
    [Abstract] [Full Text] [Related]

  • 4. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53.
    Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W.
    Cancer Lett; 2011 Feb 28; 301(2):185-92. PubMed ID: 21194832
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway.
    Peng K, Luo T, Li J, Huang J, Dong Z, Liu J, Pi C, Zou Z, Gu Q, Liu O, Zhang JT, Luo ZY.
    Acta Biochim Biophys Sin (Shanghai); 2022 May 25; 54(5):647-656. PubMed ID: 35593465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. (20S) Ginsenoside Rh2-Activated, Distinct Apoptosis Pathways in Highly and Poorly Differentiated Human Esophageal Cancer Cells.
    Li H, Han C, Chen C, Han G, Li Y.
    Molecules; 2022 Aug 31; 27(17):. PubMed ID: 36080369
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2.
    Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T, Liu Y.
    Tumour Biol; 2014 Jun 31; 35(6):5593-8. PubMed ID: 24557544
    [Abstract] [Full Text] [Related]

  • 17. JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
    Liu X, Sun Y, Yue L, Li S, Qi X, Zhao H, Yang Y, Zhang C, Yu H.
    Genet Mol Res; 2016 Sep 19; 15(3):. PubMed ID: 27706758
    [Abstract] [Full Text] [Related]

  • 18. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L, Lee J, Jang JH, Lee SH, Nan MH, Oh BC, Lee SG, Kim HH, Soung NK, Ahn JS, Kim BY.
    Bone; 2012 Jun 19; 50(6):1207-13. PubMed ID: 22484180
    [Abstract] [Full Text] [Related]

  • 19. Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway.
    Chen X, Xu T, Lv X, Zhang J, Liu S.
    J Ethnopharmacol; 2021 Jun 28; 274():113997. PubMed ID: 33705918
    [Abstract] [Full Text] [Related]

  • 20. Ginsenoside Rh2 Ameliorates Atopic Dermatitis in NC/Nga Mice by Suppressing NF-kappaB-Mediated Thymic Stromal Lymphopoietin Expression and T Helper Type 2 Differentiation.
    Ko E, Park S, Lee JH, Cui CH, Hou J, Kim MH, Kim SC.
    Int J Mol Sci; 2019 Dec 04; 20(24):. PubMed ID: 31817146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.